美国前列腺癌保守治疗人群的人口与临床特征时间变化
该研究基于SEER数据库2010-2015年数据,纳入118,415例cT1-T2a/T2NOS且Gleason 3+3或3+4的前列腺癌男性,分析选择保守治疗的相关因素。期间22,099例(18.6%)接受保守治疗,其平均年龄从66.6岁降至64.6岁,中位PSA从5.7升至6.0 ng/mL(P<.0001)。低收入组保守治疗率增长幅度大于高收入组(第三与第五收入五分位分别为152%与72%)。
要点
- 2010-2015年保守治疗率总体为18.6%,选择者平均年龄下降、PSA上升。
- 低收入人群保守治疗率增长152%,高于最高收入组的72%,差异缩小。
- Gleason 3+3、高龄、低PSA、近年份、西部治疗及高县收入与保守治疗独立相关。
核心结论
- 接受保守治疗的前列腺癌男性特征正在快速变化,年轻、较高PSA及各收入阶层人群越来越多地选择保守治疗。
- 收入相关差异缩小且监测 eligible 人群扩大是积极信号。
研究设计与样本
- 基于SEER项目「Prostate with Watchful Waiting Database」的回顾性队列分析,保守治疗由特定分类器界定。
- 纳入2010-2015年初次诊断的118,415例≥40岁、cT1-T2a及T2NOS、Gleason评分3+3或3+4的前列腺癌男性。
- 采用多变量逻辑回归分析临床与社会人口学因素与选择保守治疗的关联。
主要发现
- 2010-2015年间共22,099例(18.6%)男性接受保守治疗。
- 保守治疗者平均年龄从66.6岁降至64.6岁,中位PSA从5.7升至6.0 ng/mL,P<.0001。
- 第三与第五(最富)收入五分位保守治疗率分别增长152%与72%。
- 多变量分析显示Gleason 3+3、年龄较大、较低PSA、较近年份、西部治疗及较高县收入与保守治疗显著相关。
关键数值与推荐
- 纳入标准:年龄≥40岁,cT1-T2a及T2NOS,Gleason评分3+3或3+4。
- 保守治疗由数据库特定分类器界定。
- 多变量逻辑回归用于确定与保守治疗选择相关的因素。
临床怎么用
- 泌尿外科医生应认识到保守治疗适用人群正在向年轻及较高PSA患者扩展。
- 应关注不同收入阶层患者保守治疗可及性的改善趋势。
- 临床决策时可参考Gleason评分、年龄、PSA水平及地区实践模式等因素。
局限性
- 研究为回顾性数据库分析,保守治疗由分类器界定,可能存在分类偏倚。
- 未报告具体治疗决策过程及患者偏好等细节。
- 数据截至2015年,可能未反映最新实践变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize the role of clinical and sociodemographic factors in the use of conservative management for localized prostate cancer in the US between 2010 and 2015, and to understand how those factors evolved in light of the recent national increase in conservative management rates. METHODS: Data from the Surveillance, Epidemiology, and End Results Program "Prostate with Watchful Waiting Database," where conservative treatment was delineated by a distinct classifier, was used to evaluate factors associated with electing for conservative management at initial diagnosis (2010-2015). Men aged ≥40 years with cT1-T2a and T2NOS with Gleason score 3 + 3 and 3 + 4 were included (n = 118,415). Multivariable logistic regression was used to determine the association between clinical and sociodemographic factors and electing conservative management. RESULTS: Between 2010 and 15, a total of 22,099 (18.6%) men were managed conservatively. Mean age of men managed conservatively decreased from 66.6 to 64.6 years, and median prostate-specific antigen (PSA) increased from 5.7 to 6.0 ng/mL, P <.0001. Men with lower income experienced a greater increase in conservative management rates compared to those with high income (152% vs 72% for third and fifth [richest] income quintiles, respectively). On multivariable analysis, Gleason score 3 + 3, older age, lower PSA, more recent year, treatment in the West, and higher levels of county income were significantly associated with conservative management. CONCLUSION: Characteristics of men undergoing conservative management are rapidly changing. Younger men, men with higher PSAs, and men of all incomes are increasingly being managed conservatively. Narrowing of income-based disparities with concurrent broadening of patients considered eligible for surveillance is encouraging.
引用
- Al Hussein Al Awamlh B, Ma X, Scherr D, et al. Temporal Changes in Demographic and Clinical Characteristics of Men With Prostate Cancer Electing for Conservative Management in the United States. Urology. 2020. PMID: 31948677. doi:10.1016/j.urology.2019.12.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。